Aadi Bioscience, Inc. (AADI)

NASDAQ: AADI · IEX Real-Time Price · USD
2.02
-0.08 (-3.81%)
At close: Dec 29, 2023, 4:00 PM
2.03
0.00 (0.25%)
After-hours: Dec 29, 2023, 7:24 PM EST

Income Statement (Annual)

Millions USD. Fiscal year is Jan - Dec.
Year 20222021202020192018201720162015
Revenue
15.221.1214.58020.16000
Revenue Growth (YoY)
1258.57%-92.32%------
Cost of Revenue
1.340000000
Gross Profit
13.881.1214.58020.16000
Selling, General & Admin
40.1818.512.129.7613.499.245.270.02
Research & Development
32.6619.6715.0112.8217.8512.1511.370
Other Operating Expenses
3.7274.1601.860000
Operating Expenses
76.56112.3417.1324.4431.3421.3916.630.02
Operating Income
-62.68-111.22-2.55-24.44-11.18-21.39-16.63-0.02
Interest Expense / Income
0.230.670.82000.110.480.01
Other Expense / Income
-2.4-1.790.11-1.17-0.78-0.09-0.13-
Pretax Income
-60.51-110.09-3.48-23.27-10.4-21.4-16.98-0.03
Income Tax
00000000
Net Income
-60.51-110.09-3.48-23.27-10.4-21.4-16.98-0.03
Preferred Dividends
00.650.99000.943.930
Net Income Common
-60.51-110.74-4.47-23.27-10.4-22.34-20.91-0.03
Shares Outstanding (Basic)
239332100
Shares Outstanding (Diluted)
239332100
Shares Change
152.27%250.99%-6.04%19.62%56.56%2441.82%-82.95%-
EPS (Basic)
-2.69-12.41-1.76-8.55-4.65-15.45-367.80-0.15
EPS (Diluted)
-2.69-12.41-1.76-8.55-4.65-15.45-367.80-0.15
Free Cash Flow
-50.08-22.47-12.7-24.09-5.85-18.89-15.83-0.02
Free Cash Flow Per Share
-2.23-2.52-5.00-8.90-2.58-13.07-278.50-0.07
Gross Margin
91.23%100.00%100.00%-100.00%---
Operating Margin
-411.94%-9930.09%-17.48%--55.47%---
Profit Margin
-397.69%-9887.23%-30.62%--51.58%---
Free Cash Flow Margin
-329.15%-2006.16%-87.11%--29.00%---
EBITDA
-59.74-109.15-2.49-23.19-10.35-21.24-16.43-0.02
EBITDA Margin
-392.63%-9745.27%-17.04%--51.35%---
Depreciation & Amortization
0.540.280.180.080.050.050.070
EBIT
-60.28-109.42-2.66-23.27-10.4-21.29-16.5-0.02
EBIT Margin
-396.18%-9769.91%-18.25%--51.58%---
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).